|
Real-life data of niraparib maintenance treatment in patients with recurrent platinum-sensitive ovarian cancer. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca (Inst); GlaxoSmithKline (Inst) |
Research Funding - GlaxoSmithKline (Inst) |
|
Vibeke Anett Ingebrigtsen |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - GlaxoSmithKline |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca (Inst); GlaxoSmithKline (Inst) |
Research Funding - GlaxoSmithKline (Inst) |